MAP kinase phosphatase-1 - a new player at the nexus between sarcopenia and metabolic disease

Por Flach, Rachel J. Roth, Bennett, Anton M.
Publicado em 2010

Mitogen-Activated Protein Kinase Phosphatase-1 -A Potential Therapeutic Target In Metabolic Disease

Por Flach, Rachel J. Roth, Bennett, Anton M.
Publicado em 2010

Loss of Mitogen-activated Protein Kinase Phosphatase-1 Protects from Hepatic Steatosis by Repression of Cell Death-inducing DNA Fragmentation Factor A (DFFA)-like Effector C (CIDEC...

Por Flach, Rachel J. Roth, Qin, Hui, Zhang, Lei, Bennett, Anton M.
Publicado em 2011

Identification of Map4k4 as a Novel Suppressor of Skeletal Muscle Differentiation

Por Wang, Mengxi, Amano, Shinya U., Flach, Rachel J. Roth, Chawla, Anil, Aouadi, Myriam, Czech, Michael P.
Publicado em 2013

MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy

Por Shi, Hao, Boadu, Emmanuel, Mercan, Fatih, Le, Annie M., Flach, Rachel J. Roth, Zhang, Lei, Tyner, Kristina J., Olwin, Bradley B., Bennett, Anton M.
Publicado em 2010

Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion

Por Senol-Cosar, Ozlem, Flach, Rachel J. Roth, DiStefano, Marina, Chawla, Anil, Nicoloro, Sarah, Straubhaar, Juerg, Hardy, Olga T., Noh, Hye Lim, Kim, Jason K., Wabitsch, Martin, Scherer, Philipp E., Czech, Michael P.
Publicado no Nat Commun (2016)